Eligibility for Mounjaro and Wegovy Usage Mounjaro serves as a standalone or combined therapy for type 2 diabetes management and, with recent approvals, also targets obesity and overweight conditions with related health issues, emphasizing adherence to prescribed diets and physical activity
Kidney Use with Caution MAXILIV INJECTION should be used with caution in patients with kidney problems such as acute renal failure
Many people lose 15-20% of their body weight on these medicationsfar more than typically achieved with diet and exercise alone
Unfortunately, many existing glucoselowering agents cause unwanted consequences, such as hypoglycaemia and weight gain, which may reduce adherence to treatment 3
Genetic data should be interpreted with a qualified healthcare provider as part of a comprehensive clinical assessment
Eli Lilly SEC filings Q3 2025 (investor.lilly.com)